Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-15-activated CIK cells for post-transplant relapse in acute leukemia or myelodysplastic syndromes
2013-005446-11Phase 2Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Sep 2014
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, TCR-Engineered T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of unmodified CIK in Acute Leukaemia, myelodysplastic syndrome (MDS), sponsored by Goethe University Frankfurt. Started Sep 2014; status: completed.
02
Drugs
unmodified CIK
03
Conditions
Acute Leukaemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on 2013-005446-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005446-11.